Skip to main content
Figure 4 | Arthritis Research & Therapy

Figure 4

From: Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: meta-analysis of 51,000 patients enrolled in 52 randomized trials

Figure 4

CSULGIE incidence rates in the meta-analysis and subsequent large RCTs. *Incidence rate based on 100 patient-years of exposure to drug. CONDOR, Celecoxib vs Omeprazole and Diclofenac in Patients with Osteoarthritis and Rheumatoid Arthritis study; GI-REASONS, Gastrointestinal Randomized Event And Safety Open-Label NSAID Study; nsNSAID, nonselective nonsteroidal antiinflammatory drug.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us